Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
Laura Brandt, Jermaine D. Jones, Suky Martinez, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107859-107859
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 181
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
Ida Fredriksson, Marco Vènniro, David J. Reiner, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1050-1083
Open Access | Times Cited: 73
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
James E. Barrett, Aryan Shekarabi, Saadet Inan
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1062-1118
Open Access | Times Cited: 14
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options
Christa Corley, Ashley Craig, Safiyah Sadek, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 243, pp. 173836-173836
Open Access | Times Cited: 5
Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
E. Andrew Townsend, S. Stevens Negus, Justin L. Poklis, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107848-107848
Open Access | Times Cited: 30
Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats
E. Andrew Townsend, Paul T. Bremer, Kaycee E. Faunce, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 9, pp. 1300-1310
Open Access | Times Cited: 29
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience
Justin C. Strickland, William W. Stoops, Matthew L. Banks, et al.
Journal of the Experimental Analysis of Behavior (2022) Vol. 117, Iss. 3, pp. 384-403
Open Access | Times Cited: 15
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Confronting the challenge of failed translation in medications development for substance use disorders
S. Stevens Negus, Matthew L. Banks
Pharmacology Biochemistry and Behavior (2021) Vol. 210, pp. 173264-173264
Open Access | Times Cited: 18
The 5‐HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals
Erin J. Campbell, Yvonne Bonomo, Adam Pastor, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 18
Effects of pharmacological and environmental manipulations on choice between fentanyl and shock avoidance/escape in male and female rats under mutually exclusive and non-exclusive choice conditions
Madison M. Marcus, Samuel A. Marsh, Michelle Arriaga, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 13, pp. 2011-2021
Open Access | Times Cited: 2
5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers
Caroline A. Arout, Ziva D. Cooper, Stephanie Collins Reed, et al.
Addiction Biology (2021) Vol. 26, Iss. 4
Open Access | Times Cited: 13
Improving Translational Research Outcomes for Opioid Use Disorder Treatments
Jermaine D. Jones, Neil B. Varshneya, Thomas J. Hudzik, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 1, pp. 109-121
Open Access | Times Cited: 11
Lorcaserin: Worthy of Further Insights? Results from Recent Research
Marianna Mazza, Georgios D. Kotzalidis, Giuseppe Marano, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 278-283
Closed Access | Times Cited: 4
Epigenetics and substance use disorders: translational aspects
Gabriella M. Silva, Peter J. Hamilton
Elsevier eBooks (2024), pp. 353-378
Closed Access | Times Cited: 1
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
David R. Maguire
Pharmacology Biochemistry and Behavior (2023) Vol. 234, pp. 173673-173673
Open Access | Times Cited: 3
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial
Frances R. Levin, John J. Mariani, Martina Pavlicová, et al.
Drug and Alcohol Dependence (2021) Vol. 219, pp. 108482-108482
Open Access | Times Cited: 7
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys
Lisa R. Gerak, Charles P. France
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108991-108991
Open Access | Times Cited: 7
Neural circuits controlling choice behavior in opioid addiction
Victoria N. Chang, Jamie Peters
Neuropharmacology (2022) Vol. 226, pp. 109407-109407
Open Access | Times Cited: 5
Unpredictability as a modulator of drug self-administration: Relevance for substance-use disorders
Sally L. Huskinson
Behavioural Processes (2020) Vol. 178, pp. 104156-104156
Open Access | Times Cited: 6
Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats
Megan J. Moerke, S. Stevens Negus, Matthew L. Banks
Drug and Alcohol Dependence (2021) Vol. 231, pp. 109255-109255
Open Access | Times Cited: 6
Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders
Ken W. Grasing, Kim Burnell, Alok De
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 238-248
Open Access | Times Cited: 4
Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats
Paul Fletcher, Zhaoxia Li, Ji X, et al.
Neuropharmacology (2022) Vol. 215, pp. 109150-109150
Closed Access | Times Cited: 4
Interactions between Lorcaserin and Opioids: Ventilation and Food-Versus-Drug Choice
David R. Maguire
(2023)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top